Literature DB >> 22900209

Fabrication and development of pectin microsphere of metformin hydrochloride.

Pritam Banerjee1, Jyotirmoy Deb, Amitava Roy, Amitava Ghosh, Prithviraj Chakraborty.   

Abstract

Purpose. The objective of the proposed work is to evaluate the efficacy of Pectins to qualify them as polymers for designing an oral microsphere for the delivery of selected oral antidiabetic drug-like metformin hydrochloride. Methods. Different Microspheres formulations were prepared by the water in oil (w\o) emulsion solvent evaporation technique and subsequently evaluated for its different physical parameters as well as its in vitro and in vivo drug release study. Results. The formulations F2 (98.42) and F3 (98.03) showed a constant and high release in the dissolution profile, so among these two formulations, F2 was taken for development study, due to the better result shown over in other evaluation parameters. From the HPLC determinations after in vivo study, it had been found that the test samples and the standard sample had not shown any significant fluctuation in relation to their retention time. Conclusion. From in vitro and in  vivo results, it may be concluded that drug-loaded pectin microspheres in 1 : 1 ratio are a suitable delivery system for metformin hydrochloride and may be used for effective management of NIDDM. From this experiment, it could be concluded that as a natural polymer, pectin has potentiality in novel drug delivery system.

Entities:  

Year:  2012        PMID: 22900209      PMCID: PMC3415212          DOI: 10.5402/2012/230621

Source DB:  PubMed          Journal:  ISRN Pharm        ISSN: 2090-6145


  8 in total

1.  General solution for diffusion-controlled dissolution of spherical particles. 1. Theory.

Authors:  J Wang; D R Flanagan
Journal:  J Pharm Sci       Date:  1999-07       Impact factor: 3.534

2.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.

Authors:  T HIGUCHI
Journal:  J Pharm Sci       Date:  1963-12       Impact factor: 3.534

3.  Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma.

Authors:  R L Thies; D W Cowens; P R Cullis; M B Bally; L D Mayer
Journal:  Anal Biochem       Date:  1990-07       Impact factor: 3.365

4.  Controlled release metformin hydrochloride microspheres of ethyl cellulose prepared by different methods and study on the polymer affected parameters.

Authors:  Pratim K Choudhury; Mousumi Kar
Journal:  J Microencapsul       Date:  2009-02       Impact factor: 3.142

5.  Preparation and evaluation of zidovudine-loaded sustained-release microspheres. 2. Optimization of multiple response variables.

Authors:  K Abu-Izza; L Garcia-Contreras; D R Lu
Journal:  J Pharm Sci       Date:  1996-06       Impact factor: 3.534

6.  Antihyperglycaemic and antihyperlipidaemic effects of Nymphaea stellata in alloxan-induced diabetic rats.

Authors:  K Rajagopal; K Sasikala
Journal:  Singapore Med J       Date:  2008-02       Impact factor: 1.858

7.  Simultaneous estimation of metformin hydrochloride, pioglitazone hydrochloride, and glimepiride by RP-HPLC in tablet formulation.

Authors:  Deepti Jain; Surendra Jain; Deepak Jain; Maulik Amin
Journal:  J Chromatogr Sci       Date:  2008-07       Impact factor: 1.618

8.  Pectin/poly(lactide-co-glycolide) composite matrices for biomedical applications.

Authors:  LinShu Liu; Young Jun Won; Peter H Cooke; David R Coffin; Marshal L Fishman; Kevin B Hicks; Peter X Ma
Journal:  Biomaterials       Date:  2004-07       Impact factor: 12.479

  8 in total
  2 in total

Review 1.  Particles from preformed polymers as carriers for drug delivery.

Authors:  K Miladi; D Ibraheem; M Iqbal; S Sfar; H Fessi; A Elaissari
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

2.  MUCO-DIS: a New AFM-Based Nanoscale Dissolution Technique.

Authors:  Muhammad Usman Ghori; Jorabar Singh Nirwan; Taimoor Asim; Younes Chahid; Samia Farhaj; Zara Khizer; Peter Timmins; Barbara R Conway
Journal:  AAPS PharmSciTech       Date:  2020-05-17       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.